06/12/2018 16:18:52

True Nature Holding, Inc. Adds Healthcare Market Expert, Mr. Mark Williams, as Chief Revenue Officer and Member of the Board of Directors

ATLANTA, GA, Dec. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- True Nature Holding, Inc. (OTCQB: TNTY) (the "Company" or "True Nature") announces the appointment of Mr. Mark Williams, age 58, as Chief Revenue Officer as well as a member of its Board of Directors. Williams is a health care market expert with over 30 years experience accelerating the success of both public and private companies. As Chief Revenue Officer, Mr. Williams will be responsible for the Company’s business development and sales initiatives as well as advising the Board of Directors on potential acquisitions.  

“We are pleased to add Mark to the leadership team at True Nature Holding, Inc. and look forward to his contributions as an accomplished health care and professional services entrepreneur,” said Jim Crone, True Nature Holding’s President. “Mark brings incredible health care market subject matter expertise, professional experience in successful M&As, deep business relationships within the health care industry, international business development expertise, as well as a clear track-record of success in driving revenue growth. This is exactly what TNTY needs to continue to create value for our shareholders.”  

2005 - 2006, Mr. Williams was a Vice President of Carefx Corporation based in Scottsdale AZ that specialized in single sign-on and context management solutions and based on its success in the marketplace was sold to Harris Corporation. Mr. Williams also held roles with Microsoft Corporation and Siemens Medical where he was a Product Manager, Installation & Support Manager, and New Sales Executive. Over the course of his career Mr. Williams has personally negotiated, contracted, and closed business valued at nearly one-half a billion dollars and has successfully led three organizations through M&A.

From 2007 - 2016, Mr. Williams founded and was President and CEO of Artistry Consulting and built it into a company producing $26,856,000 in annual revenue. Artistry specialized in health care technology working with large providers and insurers across the US, Canada, UK, UAE, and Egypt.  He developed strategic relationships with Allscripts, Cerner, Epic and Siemens Medical to drive growth. Some of Mr. Williams’ marquee clients included Dignity Health, Bon Secours Health System, CHI, The Cambridge Institute, the UAE Ministry of Health and SEHA.

In 2017, Mr. Williams was a partner and senior professional services consultant at Altus Alliance, an international revenue growth firm, specializing in accelerating success through top-line revenue growth in new ventures within large companies and/or technology startups. Mr. Williams was part of a team at Altus that worked with over 200 companies, assisted in successful IPO's and M&A events for 14 companies, and generated more than $200M directly for clients through business development and sales. In 2016 and continuing into 2017, Mr. Williams also served as a Director for the Washington Medical Information Network and was Senior Vice President of Orion Health overseeing professional services. 

“TNTY is a great platform to apply my industry knowledge, leverage valued professional relationships, and use my professional experience to propel growth,” commented Mr. Williams. “TNTY is bringing together a top-notch team of team of skilled financial, operational, and investor value creation subject matter experts that are second to none. I very much look forward to working with the team to further TNTY’s success.”

Mr. Williams holds degrees in Business and Engineering from the University of Utah, 1985.

The Mission of True Nature Holding, Inc.

To leverage new technologies and services to improve healthcare and outcome for individuals, their families, and their pets. We believe we can reduce the cost of healthcare while improving the quality of life using Telehealth and Telemedicine Solutions.

We are building healthcare applications that focus on patient engagement, care coordination, remote monitoring, data analytics, and may include Blockchain RX(TM) to provide applications for market participants in healthcare through the encryption of sensitive data.

Our approach is to develop these business opportunities as individual "threads" in response to client needs, ultimately creating an end-to-end set of solutions from the end user up to the healthcare provider, or veterinary professional. Further, we expect to assist suppliers to the healthcare industry by allowing them to access unique technologies that bind them with their clients in a "top-down" distribution model.

We recognize it will take the investment of major market participants like Apple, Amazon, IBM, hospitals, healthcare networks, pharmacy and other providers for us to achieve critical mass. In consideration of this reality, we expect to work with these market makers in collaboration, and in support of the ultimate user, the individual, and their pets. The day of "direct-to-consumer" healthcare, including "the humanization of our pets" is upon us, and we hope to be key parties to their evolution, and success.

Statement Under the Private Securities Litigation Reform Act

As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release contains forward-looking statements pertaining to future, anticipated, or projected plans, performances, and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect True Nature Holding, Inc. is included in the Company's filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.

Jim Crone

+1-844-383-8689

Jcrone@truenatureholding.com

True Nature Holding, Inc..jpg

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
17 Feb
VWS
  Jeg har nu haft lidt tid til at læse det seneste årsregnskab fra Vestas. Jeg har forsøgt at opsumm..
62
21 Feb
VELO
Især 2 ting har fanget min opmærksomhed i de seneste døgn. 1) Astellas er udtrådt af AST )American S..
22
15 Feb
VELO
Jeg kan se på FB-gruppen at er der en diskussion omkring præparatet fra Hansa Medical det evt. ramme..
19
21 Feb
CHEMM
Vi sidder her under træet og bliver helt skizofrene. Hvad skete der lige her. Tælleren tog et hop op..
18
19 Feb
FING-B
Så lukkede FPC over den gamle modstand i dag i 19,55 modstanden var 19,47 og næste stop er nu 21,786..
18
15 Feb
VELO
Jeg har solgt mine Veloxis-aktier, for der er nogle mekanismer i stigningerne i både Chemometec og i..
18
18 Feb
VWS
VESTAS LEADS BREAK-AWAY GROUP OF ONSHORE TURBINE MAKERS (fra 16% til 22% af det totale marked for la..
17
18 Feb
PNDORA
Det er netop kommet frem, at tyske BAFIN, svarende til Finanstilsynet i Dk., har forbudt short posit..
17
19 Feb
VELO
Til dem af jer der ikke er med i FB gruppen: Canada havde, sammen med US, lukket i går. Teorien er, ..
16
18 Feb
CHEMM
Puha, ja hvad venter vi nu på,…… vi trofaste og frelste Chemo aktionærer, Noten, den romantiske og ..
15

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

Related news
22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen
2
Bragar Eagel & Squire, P.C. is Investigating Domino’s Pizza, Inc. (DPZ) on Behalf of Stockholders and Encourages DPZ Investors to Contact the Firm
3
Melinta Therapeutics Announces One-for-Five Reverse Stock Split
4
Odyssey Moon Extends Its Heartfelt Congratulations to SpaceIL for the Successful Launch of the First Non-Governmental Spacecraft to the Moon
5
Bragar Eagel & Squire, P.C. is Investigating Vanda Pharmaceuticals Inc. (VNDA) on Behalf of Stockholders and Encourages VNDA Investors to Contact the Firm

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 February 2019 09:12:52
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20190215.1 - EUROWEB7 - 2019-02-22 10:12:52 - 2019-02-22 09:12:52 - 1000 - Website: OKAY